Abstract:Sporadic Alzheimer’s disease (AD) is a neurodegenerative disease characterized by neurofibrillary tangles composed of hyperphosphorylated tau proteins and amyloid‐beta (Aβ) plaques. Together, these two histopathological detriments in the brain lead to progressive cognitive decline. Glycogen synthase kinase‐3 β (GSK3β), a kinase found abundantly in the brain, has been implicated in the development of these AD pathologies. GSK3β remains constituently active until phosphorylated at its inhibitory Ser9 residue. When active, GSK3β is capable of inducing tau hyperphosphorylation and can phosphorylate amyloid‐precursor protein (APP), influencing greater levels of Aβ peptide production. Lithium (Li), a GSK3β inhibitor, has been suggested as an AD prophylaxis. However, Li has also been associated with several dose‐dependent adverse side effects. The purpose of this study was thus to examine the effects of a prophylactic low‐dose Li supplementation on brain GSK3β signaling and activity. C57BL/6J male mice were given 10mg/kg/day Li or no Li in their drinking water for 6 weeks (n=12/group) and the prefrontal cortex (PFC) and hippocampal (HIP) tissues were collected for GSK3 activity assay and western blot analyses. Li mice had increased serum Li concentrations (p<0.0001) and decreased hippocampal GSK3 activity (p=0.06) as compared to control mice. pAkt Thr308 phosphorylation, a kinase immediately upstream of GSK3β capable of inducing inhibitory pGSK3β Ser9 phosphorylation, was increased in the PFC of Li mice compared to control mice (p<0.05). However, no differences in pGSK3β Ser9 or Tyr216, an activating residue, were observed between control and Li mice in both the PFC and HIP. Changes in GSK3 activity without changes in inhibitory Ser9 phosphorylation may suggest that a longer supplementation is needed to affect significant changes in the brain. Furthermore, these results demonstrate that the phosphorylation status of GSK3β may not always be a direct translation of its activity. This highlights the importance of measuring GSK3β activity alongside of measures of upstream kinases (i.e. PI3K/Akt signaling) and downstream targets to obtain a better indication of GSK3β’s overall activity within the brain. Overall, this initial work provides evidence that Li can inhibit hippocampal GSK3 activity and alter the phosphorylation status of upstream kinases at a low‐dose. Future work will examine Li’s potential prophylactic effects in a diseased model which better mimics AD (i.e. aged and metabolically‐distressed mice). This is important to further elucidate the efficacy of low‐dose Li in the prevention of AD pathologies. Support or Funding Information This work is supported by the Alzheimer Society of Brant, Haldimand Norfolk, Hamilton Halton and NSERC.

Effects of glycogen synthase kinase-3 activity inhibition on cognitive, behavioral, and hippocampal ultrastructural deficits in adulthood associated with adolescent methamphetamine exposure

LiCl Pretreatment Ameliorates Adolescent Methamphetamine Exposure-Induced Long-Term Alterations in Behavior and Hippocampal Ultrastructure in Adulthood in Mice.

Glycogen Synthase Kinase 3 Beta In The Nucleus Accumbens Core Is Critical For Methamphetamine-Induced Behavioral Sensitization

Role of GSK3β/α-synuclein Axis in Methamphetamine-Induced Neurotoxicity in PC12 Cells

Methamphetamine Exposure in Adolescent Impairs Memory of Mice in Adulthood Accompanied by Changes in Neuroplasticity in the Dorsal Hippocampus

Astrocyte-derived lactate/NADH alters methamphetamine-induced memory consolidation and retrieval by regulating neuronal synaptic plasticity in the dorsal hippocampus

GSK-3β Deletion in Dentate Gyrus Excitatory Neuron Impairs Synaptic Plasticity and Memory

GSK3 Activity is Decreased in The Hippocampus of Male Mice Supplemented with Low‐Dose Lithium in Drinking Water

Distinct Roles of Methamphetamine in Modulating Spatial Memory Consolidation, Retrieval, Reconsolidation and the Accompanying Changes of ERK and CREB Activation in Hippocampus and Prefrontal Cortex

The neuroprotective effect of LCZ696 on methamphetamine-induced cognitive impairment in mice

Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: role for nitrotyrosination

Loss of Object Recognition Memory Produced by Extended Access to Methamphetamine Self-Administration is Reversed by Positive Allosteric Modulation of Metabotropic Glutamate Receptor 5

Continuous GSK-3β overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice.

Single-dose methamphetamine administration impairs ORM retrieval in mice via excessive DA-mediated inhibition of PrL Glu activity

The effects of early exposure to MK-801 during environmental enrichment on spatial memory, methamphetamine self-administration and cue-induced renewal in rats

Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation

Neuroprotective effect of histamine H3 receptor blockade on methamphetamine-induced cognitive impairment in mice

Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice

LY235959 attenuates development phase of Methamphetamine-Induced behavioral sensitization through the PP2A/B - AKT cascade in the dorsal striatum of C57/BL6 mice

Lithium Attenuates Scopolamine-Induced Memory Deficits with Inhibition of GSK-3β and Preservation of Postsynaptic Components.

Glycogen Synthase Kinase 3β in the Nucleus Accumbens Core Mediates Cocaine‐induced Behavioral Sensitization